Author:
Pinto Cathy Anne,Balantac Zaneta,Mt-Isa Shahrul,Liu Xinyue,Bracco Oswaldo L,Clarke Harrison,Tervonen Tommi
Subject
Drug Discovery,Pharmacology
Reference44 articles.
1. European Medicines Agency. Benefit-risk methodology. Research projects. Accessed July 16, 2020. https://www.ema.europa.eu/en/about-us/support-research/benefit-risk-methodology.
2. IMI-PROTECT. What is benefit-risk assessment? Accessed July 16, 2020. http://protectbenefitrisk.eu/PPI2.html.
3. Structured benefit-risk assessment across the product lifecycle: practical considerations;Smith;Ther Innov Regul Sci,2017
4. Can standardisation of the public assessment report improve benefit-risk communication?;Keyter;Front Pharmacol,2020
5. Structured frameworks to increase the transparency of the assessment of benefits and risks of medicines: current status and possible future directions;Pignatti;Clin Pharmacol Ther,2015
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Medical Statistics in Drug Development and Regulatory Approval;Advances in Bioinformatics and Biomedical Engineering;2024-07-18